Literature DB >> 18432944

In situ staining using MHC class I tetramers.

Pamela J Skinner1, Ashley T Haase.   

Abstract

The invention of MHC-tetramer technology to label antigen-specific T cells has lead to a greatly enhanced understanding of T lymphocyte biology. This protocol describes the use of MHC class I tetramers to stain antigen-specific T cells in tissue sections. In situ tetramer staining (IST) can be used to determine the localization, abundance, and phenotype of antigen-specific T cells in native environments and in three-dimensional space. IST is broadly applicable because it can be used to stain essentially any antigen-specific T cell in any tissue for which MHC tetramers are available. IST can be combined with histochemistry and/or immunohistochemistry to permit visualization and characterization of antigen-specific T cells relative to other cell types in stained tissue sections. Thus, IST is a useful and valuable component of MHC-tetramer technology.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 18432944     DOI: 10.1002/0471142735.im1704s64

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  12 in total

1.  In situ detection of autoreactive CD4 T cells in brain and heart using major histocompatibility complex class II dextramers.

Authors:  Chandirasegaran Massilamany; Arunakumar Gangaplara; Ting Jia; Christian Elowsky; Qingsheng Li; You Zhou; Jay Reddy
Journal:  J Vis Exp       Date:  2014-08-01       Impact factor: 1.355

2.  Induction of vaginal-resident HIV-specific CD8 T cells with mucosal prime-boost immunization.

Authors:  H-X Tan; A K Wheatley; R Esterbauer; S Jegaskanda; J J Glass; D Masopust; R De Rose; S J Kent
Journal:  Mucosal Immunol       Date:  2017-10-25       Impact factor: 7.313

3.  In Situ MHC-tetramer Staining and Quantitative Analysis to Determine the Location, Abundance, and Phenotype of Antigen-specific CD8 T Cells in Tissues.

Authors:  Shengbin Li; Gwantwa Mwakalundwa; Pamela J Skinner
Journal:  J Vis Exp       Date:  2017-09-22       Impact factor: 1.355

Review 4.  Interrogating the repertoire: broadening the scope of peptide-MHC multimer analysis.

Authors:  Mark M Davis; John D Altman; Evan W Newell
Journal:  Nat Rev Immunol       Date:  2011-07-15       Impact factor: 53.106

Review 5.  Inflammation on the mind: visualizing immunity in the central nervous system.

Authors:  Silvia S Kang; Dorian B McGavern
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

6.  In Situ Peptide-MHC-II Tetramer Staining of Antigen-Specific CD4+ T Cells in Tissues.

Authors:  Thamotharampillai Dileepan; Hyeon O Kim; P Patrick Cleary; Pamela J Skinner
Journal:  PLoS One       Date:  2015-06-11       Impact factor: 3.240

7.  Comparison of Vibratome and Compresstome sectioning of fresh primate lymphoid and genital tissues for in situ MHC-tetramer and immunofluorescence staining.

Authors:  Hadia M Abdelaal; Hyeon O Kim; Reece Wagstaff; Ryoko Sawahata; Peter J Southern; Pamela J Skinner
Journal:  Biol Proced Online       Date:  2015-01-07       Impact factor: 3.244

8.  Localized populations of CD8 MHC class I tetramer SIV-specific T cells in lymphoid follicles and genital epithelium.

Authors:  Jung Joo Hong; Matthew R Reynolds; Teresa L Mattila; Aaron Hage; David I Watkins; Christopher J Miller; Pamela J Skinner
Journal:  PLoS One       Date:  2009-01-05       Impact factor: 3.240

9.  Direct staining with major histocompatibility complex class II dextramers permits detection of antigen-specific, autoreactive CD4 T cells in situ.

Authors:  Chandirasegaran Massilamany; Arunakumar Gangaplara; Ting Jia; Christian Elowsky; Guobin Kang; Jean-Jack Riethoven; Qingsheng Li; You Zhou; Jay Reddy
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

10.  Location and dynamics of the immunodominant CD8 T cell response to SIVΔnef immunization and SIVmac251 vaginal challenge.

Authors:  Arun K Sasikala-Appukuttan; Hyeon O Kim; Nikilyn J Kinzel; Jung Joo Hong; Anthony J Smith; Reece Wagstaff; Cavan Reilly; Michael Piatak; Jeffrey D Lifson; R Keith Reeves; R Paul Johnson; Ashley T Haase; Pamela J Skinner
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.